These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20021455)

  • 1. E2F1-mediated apoptosis as a target of cancer therapy.
    Wu Z; Yu Q
    Curr Mol Pharmacol; 2009 Jun; 2(2):149-60. PubMed ID: 20021455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E2F family and the role of E2F1 in apoptosis.
    Wu Z; Zheng S; Yu Q
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2389-97. PubMed ID: 19539777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.
    Engelmann D; Pützer BM
    Drug Resist Updat; 2010; 13(4-5):119-31. PubMed ID: 20675184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation.
    Pickering MT; Kowalik TF
    Oncogene; 2006 Feb; 25(5):746-55. PubMed ID: 16186801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
    Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E2F1/Rb and p53/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy.
    Udayakumar T; Shareef MM; Diaz DA; Ahmed MM; Pollack A
    Semin Radiat Oncol; 2010 Oct; 20(4):258-66. PubMed ID: 20832018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTSL2 is a pro-apoptotic target of E2F1 and a modulator of histone deacetylase inhibitor and DNA damage-induced apoptosis.
    Wong CH; Wu Z; Yu Q
    Oncogene; 2014 Mar; 33(10):1249-57. PubMed ID: 23542171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.
    Pan H; Yin C; Dyson NJ; Harlow E; Yamasaki L; Van Dyke T
    Mol Cell; 1998 Sep; 2(3):283-92. PubMed ID: 9774967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
    Chen Q; Hung FC; Fromm L; Overbeek PA
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 apoptosis counterattacked: evil strikes back.
    Pützer BM; Engelmann D
    Trends Mol Med; 2013 Feb; 19(2):89-98. PubMed ID: 23219173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells.
    Sun B; Wingate H; Swisher SG; Keyomarsi K; Hunt KK
    Cell Cycle; 2010 Mar; 9(6):1122-30. PubMed ID: 20237430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 is the target of a UV-inducible apoptosis switch and a node for UV signaling.
    Knezevic D; Zhang W; Rochette PJ; Brash DE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11286-91. PubMed ID: 17586682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR signaling inhibits E2F1-induced apoptosis in vivo: implications for cancer therapy.
    Ginsberg D
    Sci STKE; 2007 Jan; 2007(371):pe4. PubMed ID: 17264315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.
    Liontos M; Niforou K; Velimezi G; Vougas K; Evangelou K; Apostolopoulou K; Vrtel R; Damalas A; Kontovazenitis P; Kotsinas A; Zoumpourlis V; Tsangaris GT; Kittas C; Ginsberg D; Halazonetis TD; Bartek J; Gorgoulis VG
    Am J Pathol; 2009 Jul; 175(1):376-91. PubMed ID: 19541929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage.
    Zhang XP; Liu F; Wang W
    J Biol Chem; 2010 Oct; 285(41):31571-80. PubMed ID: 20685653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy.
    Martinez JC; Palomino JC; Samaniego R; Sepulveda JM; Cabello A; Ricoy JR
    Cancer; 2008 Jul; 113(1):166-74. PubMed ID: 18459177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution.
    Iglesias-Ara A; Zenarruzabeitia O; Buelta L; Merino J; Zubiaga AM
    Cell Death Differ; 2015 Oct; 22(10):1577-89. PubMed ID: 25656653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression level is a key determinant of E2F1-mediated cell fate.
    Shats I; Deng M; Davidovich A; Zhang C; Kwon JS; Manandhar D; Gordân R; Yao G; You L
    Cell Death Differ; 2017 Apr; 24(4):626-637. PubMed ID: 28211871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human ARF binds E2F1 and inhibits its transcriptional activity.
    Eymin B; Karayan L; Séité P; Brambilla C; Brambilla E; Larsen CJ; Gazzéri S
    Oncogene; 2001 Mar; 20(9):1033-41. PubMed ID: 11314038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.